ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Autoimmune Skin Disease"

  • Abstract Number: 775 • 2019 ACR/ARP Annual Meeting

    Cutaneous Gene Expression Signatures in Juvenile Myositis Reveal a Prominent IFN Signature in Lesional Skin

    Jessica Turnier1, Celine Berthier 1, Lam Tsoi 1, Lori Lowe 1, Gabrielle Morgan 2, Johann Gudjonsson 1, Lauren Pachman 2 and J. Michelle Kahlenberg 1, 1University of Michigan, Ann Arbor, MI, 2Northwestern University, Chicago

    Background/Purpose: Skin inflammation can herald systemic disease manifestations and disease chronicity in juvenile myositis (JM), yet we lack an understanding of the pathogenic mechanisms driving…
  • Abstract Number: 1939 • 2019 ACR/ARP Annual Meeting

    Analysis of Discoid Lupus Erythematosus (DLE) Gene Expression Reveals Dysregulation of Pathogenic Pathways Associated with Infiltrating Immune/Inflammatory Cells

    Frances Harris1, Sarah Heuer 2, Robert Robl 2, Prathyusha Bachali 2, Adam Labonte 2, Benjamin Chong 3, Michelle Catalina 2, Peter Lipsky 2 and Amrie Grammer 2, 1RILITE Research Institute, Charlottesville, VA, 2RILITE Research Institute, Charlottesville, 3University of Texas Southwestern, Dallas

    Background/Purpose: DLE is a chronic, scarring inflammatory autoimmune disease of the skin. The precise molecular pathways underlying DLE pathogenesis have not been fully delineated. To…
  • Abstract Number: 99 • 2018 ACR/ARHP Annual Meeting

    DC-Hil+ Myeloid-Derived Suppressor Cells Are Elevated in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients

    Stephanie Florez-Pollack1, Lin-chiang Tseng1, Masato Kobayashi1, Gregory Hosler1,2, Kiyoshi Ariizumi1 and Benjamin F. Chong1, 1Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, 2Propath, Dallas, TX

     Background/Purpose: Myeloid derived suppressor cells (MDSCs) are major T cell suppressors, and their dysfunction has been implicated in the pathophysiology of autoimmune diseases. MDSCs suppress…
  • Abstract Number: 2040 • 2013 ACR/ARHP Annual Meeting

    Pilot Study Of Abatacept In Patients With Refractory Autoimmune Chronic Urticaria

    Clifton O. Bingham III1, Marilyn Towns1 and Susan J. Bartlett2, 1Rheumatology, Johns Hopkins University, Baltimore, MD, 2Clinical Epidemiology, McGill University, Montreal, QC, Canada

    Background/Purpose: Associations between chronic urticaria (CU) with autoantibodies and other autoimmune conditions have implicated T cells in CU initiation and/or propagation. Many patients (pts) have…
  • Abstract Number: 1935 • 2013 ACR/ARHP Annual Meeting

    Validation Of The Cutaneous Dermatomyositis Disease Area and Severity Index: Characterizing Severity and Assessing Responsiveness To Clinical Change

    Cynthia O. Anyanwu1,2, David Fiorentino3, Lorinda Chung4, Yanli Wang5, Kathleen J. Propert6 and Victoria P. Werth7,8, 1Department of Dermatology, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, 2Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, 3Dermatology, Stanford University School of Medicine, Redwood City, CA, 4Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, 5Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 6Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 7Department of Dermatology, Veteran Affairs Medical Center, Philadelphia, PA, 8Department of Dermatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Translational research and clinical trials necessitate validated outcome measures to reliably assess disease progression and treatment efficacy. The Cutaneous Dermatomyositis Disease Area and Severity…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.